Investor Alert: Pomerantz Law Firm Investigates Abeona Therapeutics for Potential Securities Fraud
Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by Abeona Therapeutics Inc. (NASDAQ: ABEO) and certain of its officers and directors on behalf of investors. The investigation was prompted after Abeona disclosed in a press release that only four out of five treatments with ZEVASKYN were recognized for revenue due to insufficient product batches, leading to a 14.95% drop in stock price. The firm is known as one of the premier legal entities specializing in corporate and securities litigation. Investors are encouraged to contact Pomerantz LLP if they wish to join any potential class action related to this matter.
Tickers: $ABEO
Topics: financial_disclosure investor_protection stock_price_drop